trending Market Intelligence /marketintelligence/en/news-insights/trending/_wdjloxwpnvfbl_acum6iq2 content esgSubNav
In This List

Anatara Lifesciences CEO retires; interim named

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Anatara Lifesciences CEO retires; interim named

Anatara Lifesciences Ltd. said Mel Bridges retired as CEO.

Executive director Tracie Ramsdale was named interim CEO.

Jay Hetzel, a nonexecutive director of Anatara, was also appointed interim chairman.

Brisbane, Australia-based Anatara Lifesciences develops nonantibiotic oral solutions for gastrointestinal diseases.